Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz.
about
Individualization of antiretroviral therapy--pharmacogenomic aspectEfavirenz and the CNS: what we already know and questions that need to be answeredQuality of Sleep in an HIV Population on Antiretroviral Therapy at an Urban Tertiary Centre in Lagos, Nigeria.Burden of sleep disturbances and associated risk factors: A cross-sectional survey among HIV-infected persons on antiretroviral therapy across China.Neurological and psychiatric adverse effects of antiretroviral drugs.Efavirenz modulation of sleep spindles and sleep spectral profile.Prediction of neuropsychiatric adverse events associated with long-term efavirenz therapy, using plasma drug level monitoring.Pharmacogenomics of antimicrobial agents.Population pharmacokinetic/pharmacogenetic model for optimization of efavirenz therapy in Caucasian HIV-infected patients.Association of Markers of Inflammation with Sleep and Physical Activity Among People Living with HIV or AIDSInsomnia symptoms and HIV infection among participants in the Women's Interagency HIV Study.Prevalence and factors associated with sleep disturbances among early-treated HIV-infected personsEfavirenz for HIV-1 infection in adults: an overview.The nonnucleoside reverse transcriptase inhibitors efavirenz and nevirapine in the treatment of HIV.Neuropsychometric correlates of efavirenz pharmacokinetics and pharmacogenetics following a single oral dose.Neuropsychiatric side effects of efavirenz therapy.Efavirenz: a review.Cost-effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice.Qualitative study of the quality of sleep in marginalized individuals living with HIV.The pharmacologic management of insomnia in patients with HIV.Effect of rifampicin-based antitubercular therapy and the cytochrome P450 2B6 516G>T polymorphism on efavirenz concentrations in adults in South Africa.The impact of pharmacogenetics on HIV therapy.Multiphenotype association study of patients randomized to initiate antiretroviral regimens in AIDS Clinical Trials Group protocol A5202.A systematic review of the psychiatric side-effects of efavirenz.Antiretroviral drug-related toxicities - clinical spectrum, prevention, and management.Impact of CYP polymorphisms, ethnicity and sex differences in metabolism on dosing strategies: the case of efavirenz.Pharmacogenetics of antiretroviral therapy.Dual antiviral therapy for HIV and hepatitis C - drug interactions and side effects.Cytochrome 2B6 polymorphism and efavirenz-induced central nervous system symptoms : a substudy of the ANRS ALIZE trial.Engagement in Care, Psychological Distress, and Resilience are Associated with Sleep Quality among HIV-Positive Gay, Bisexual, and Other Men Who Have Sex with Men.Impact of pharmacogenetics on CNS side effects related to efavirenz.Pharmacogenetics of efavirenz discontinuation for reported central nervous system symptoms appears to differ by race.Caffeine and Insomnia in People Living With HIV From the Miami Adult Studies on HIV (MASH) Cohort.Drug interactions in HIV-infected patients treated for hepatitis C.Effect of Valerian in Preventing Neuropsychiatric Adverse Effects of Efavirenz in HIV-Positive Patients: A Pilot Randomized, Placebo-Controlled Clinical Trial.Sleep Disturbance Among HIV-Infected and Uninfected Veterans.Impact of efavirenz pharmacokinetics and pharmacogenomics on neuropsychological performance in older HIV-infected patients.Changes in sleep quality and brain wave patterns following initiation of an efavirenz-containing triple antiretroviral regimen.Long-term efficacy and safety of efavirenz dose reduction to 200 mg once daily in a Caucasian patient with HIV.Influence of 516G>T polymorphisms at the gene encoding the CYP450-2B6 isoenzyme on efavirenz plasma concentrations in HIV-infected subjects.
P2860
Q28070574-B6FBEA74-521E-4B01-85F8-7C42CB44DE42Q28085028-4CE02952-BD9F-486A-8A00-50C28D7A0ED1Q33607553-99525030-9262-41D4-AF5F-E5BD73D8A15DQ33807989-B189C32F-CE77-495A-AD53-AAFB0ECAF4B9Q34039419-145DF2B4-410A-4302-B118-4ADEE4B56A16Q34433247-7B42D703-3FEF-4A5B-A7F7-A179A128C721Q34464997-953E17A0-FEE5-4040-86A7-C0E5F0D3190CQ34977413-F0D89374-911D-45C8-A8A1-85DA32A13DE1Q35364120-F4B9937E-10E2-4EA3-B0DD-7CFAE4950CC0Q35612351-8A8D2C70-2C1F-49D3-8E58-BDBC88525199Q35623512-CA18E438-F68E-4CCD-9B33-CDC7128AD313Q35906888-89880684-1153-4CC3-BBDF-601D1CD99A2FQ35917519-732E5E6A-51B9-4290-AEFF-B9BD1EE8D74BQ36271415-FAFF548B-4C51-4DC4-860A-E9A9DA094F45Q36729929-FD2118D3-FF98-4F93-AB37-D9102539F6F7Q36762436-B03F6419-F85B-4501-8FA3-DBF3E128DD1CQ36787311-3B75B555-A5DF-41C8-B2E2-E36A7BC86729Q36801543-5021D861-91CD-4A85-BCB9-592544305B77Q36943576-97EDEEC8-2BD5-4614-AD86-023BA065BFA0Q37234441-E84A8887-AA18-43CF-8A99-2F92C1DF0F2CQ37334180-F7B8A838-3DE8-4C81-939C-B54F72F68F25Q37405140-CD995ECF-0FDA-46CD-BFEF-960DEC120219Q37617319-1FAD9FB7-D916-4249-AD4D-A52CF0D2F8F2Q37864141-BB0B04C7-C5C7-4250-A375-62F743D2A131Q38111430-EFD266C7-52F9-404A-B803-CA7F14420CAEQ38175870-17052F8C-B783-441C-A713-1CD492BF9CA8Q38221179-4150AE06-6FC7-4843-829C-AA6DD4A9168DQ38554604-9E060D7D-F2C5-4B70-B79E-FBC4FF0CCD4EQ38987587-51A79883-2CB4-45EA-A737-F91AA291436EQ39303354-0B773CE4-FEB2-4768-A122-D465234597E8Q39383647-1C1D4020-39B2-4EEC-ADB6-BF506359C5EBQ39503882-35E9CC5A-AD9A-4006-9433-84956F7B907AQ40074833-76380326-F360-46BC-8D3B-30F09071D897Q40143109-E2B4E911-E702-4E47-8F3F-BFC14EECF4A9Q40223622-4D5C86AA-455F-4EA0-BBC3-78C2CDC2556CQ40427690-F9121BB8-7B3C-4E65-9266-ED01A550147FQ40531475-9C5D2968-1A7B-46CD-9F47-6FF1C6A55622Q42683724-29A998A2-2027-4D8F-8484-9F9817FC6DDBQ43074797-A2B081A2-58E0-421E-985E-028CA1F9C8EDQ46433672-46366F0A-2531-4F56-9DDE-461D0127BCE9
P2860
Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz.
@en
Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz.
@nl
type
label
Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz.
@en
Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz.
@nl
prefLabel
Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz.
@en
Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz.
@nl
P2093
P2860
P356
P1476
Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz.
@en
P2093
Apolinar Rodríguez-Albariño
Daniel González de Requena
Juan González-Lahoz
Lucía Gallego
Pablo Barreiro
Rafael del Río
P2860
P304
P356
10.1086/380791
P407
P577
2004-01-09T00:00:00Z